Belpointe Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$719K Sell
2,815
-623
-18% -$153K 0.02% 628
2026
Q2
$643K Buy
3,438
+271
+9% +$49.8K 0.02% 636
2026
Q1
$598K Sell
3,167
-562
-15% -$118K 0.02% 635
2025
Q4
$741K Buy
3,729
+71
+2% +$14.3K 0.03% 540
2025
Q3
$743K Buy
3,658
+596
+19% +$106K 0.03% 502
2025
Q2
$539K Buy
3,062
+1,075
+54% +$162K 0.02% 553
2025
Q1
$267K Sell
1,987
-248
-11% -$32.7K 0.01% 761
2024
Q4
$368K Sell
2,235
-946
-30% -$141K 0.02% 589
2024
Q3
$529K Buy
+3,181
New +$481K 0.03% 488
2023
Q2
– Sell
-588
Closed -$34.9K – 3105
2023
Q1
$34.9K Buy
588
+285
+94% +$15.8K ﹤0.01% 1943
2022
Q4
$14.8K Buy
+303
New +$14K ﹤0.01% 2409

Other funds holding THC

Belpointe Asset Management's THC Position: Q3 2026 in Review

Belpointe Asset Management reduced its Tenet Healthcare (THC) stake by 18% in Q3 2026, selling an estimated $153K and leaving 2,815 shares worth $719K. The position accounts for 0.02% of the portfolio, ranked #628.

Belpointe Asset Management first reported a position in THC in Q4 2022 and has held it in 11 quarters since. The position peaked at $743K in Q3 2025. 783 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Belpointe Asset Management held 2,815 shares of Tenet Healthcare worth $719K as of Q3 2026.
  • Belpointe Asset Management sold 623 Tenet Healthcare shares in Q3 2026, an estimated $153K.
  • Tenet Healthcare made up 0.02% of Belpointe Asset Management's portfolio in Q3 2026, its #628 holding.
  • Belpointe Asset Management first reported a position in Tenet Healthcare in Q4 2022 and has held it in 11 quarters since.
  • Belpointe Asset Management's Tenet Healthcare position peaked at $743K in Q3 2025.
  • 783 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Belpointe Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.